A genetically modified pig kidney was successfully transplanted into a human patient, functioning for a record 271 days before being removed. The recipient, Tim Andrews, who suffers from end-stage kidney disease caused by type 2 diabetes, experienced the procedure as a significant milestone in the search for alternatives to human organ transplants.

The experimental transplant aimed to address the critical shortage of available human kidneys for patients with organ failure. By using genetically altered pig organs designed to reduce the risk of rejection, researchers sought to create a viable bridge for patients awaiting human transplants.

Andrews’ transplant demonstrated that pig kidneys could perform essential functions within the human body for an extended period. During the months following the procedure, the transplanted kidney enabled Andrews to live without reliance on dialysis, offering him a glimpse of normalcy and independence. He described the experience as a source of hope and a chance to reclaim his life beyond the constraints of kidney disease treatment.

Despite the initial success, the pig kidney eventually developed complications. Blood clots formed within the organ, leading to its removal. Following the removal of the pig kidney, Andrews received a human kidney transplant in January to replace the failing experimental organ.

This case represents a notable advance in xenotransplantation—the practice of transplanting organs from one species to another—highlighting the potential for genetically modified animal organs to serve as temporary solutions for patients facing organ shortages. While challenges remain, including managing immune response and preventing clotting, the achievement marks a significant step toward expanding the pool of transplantable organs and reducing wait times for patients with end-stage organ failure.